Follow the 하나제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 하나제약 has recorded 30 public disclosures. The latest transaction was reported on 2 June 2026 (Purchase). Among the most active insiders: 이일기. Every trade is openly available.
30
Insider Decl.
n/a
Thresholds
€978,442
17 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
Buys €978,442n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.